Melatonin synthesis and secretion pathway

The melatonin synthesis and secretion pathway is a critical neuroendocrine system responsible for regulating the body's internal clock and sleep-wake cycles (StatPearls, NBK534823). This pathway primarily occurs in the pineal gland, where the amino acid tryptophan is converted into serotonin and subsequently into melatonin through the action of enzymes such as serotonin N-acetyltransferase (AANAT) and acetylserotonin O-methyltransferase (ASMT) (UniProt, Q16613; UniProt, P46597). Melatonin production is tightly regulated by the suprachiasmatic nucleus (SCN) of the hypothalamus, which responds to light-dark cycles by stimulating or inhibiting sympathetic input to the pineal gland via norepinephrine release (PubMed, 29361301). Once secreted, melatonin acts on MT1 and MT2 G protein-coupled receptors to signal the onset of the biological night and facilitate sleep (NIH, NCCIH). Dysregulation of this pathway is linked to various conditions, including insomnia, jet lag, and mood disorders like seasonal affective disorder (PubMed, 31970309). Pharmacological interventions include melatonin receptor agonists like ramelteon and tasimelteon used to treat sleep disturbances, as well as certain antidepressants like agomelatine that modulate melatonin signaling (PubChem, CID 896; PubChem, CID 209661). Understanding this pathway is essential for managing circadian rhythm disruptions and their associated systemic health impacts.

Other names

Melatonin biosynthetic pathwayPineal melatonin synthesisMelatonin signaling pathway

Drugs targeting this pathway primarily act as agonists of the MT1 and MT2 G protein-coupled receptors to mimic endogenous melatonin, or they modulate the enzymatic synthesis and metabolic degradation of melatonin to shift circadian phases (StatPearls, NBK534823; PubMed, 29361301).